Format

Send to

Choose Destination
J Clin Invest. 2019 May 1;129(5):2164. doi: 10.1172/JCI129277. Epub 2019 May 1.

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.

Supplemental Content

Full text links

Icon for American Society for Clinical Investigation Icon for PubMed Central
Loading ...
Support Center